Nuveen Asset Management Portfolio holdings
Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.
Top Buys
| 1 |
Merck
MRK
|
+$362M |
| 2 |
Prologis
PLD
|
+$358M |
| 3 |
NVIDIA
NVDA
|
+$305M |
| 4 |
Corteva
CTVA
|
+$235M |
| 5 |
Atlassian
TEAM
|
+$226M |
Top Sells
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.8B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$308M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$261M |
| 4 |
iShares Russell 1000 Growth ETF
IWF
|
+$259M |
| 5 |
Danaher
DHR
|
+$243M |
Sector Composition
| 1 | Technology | 22.57% |
| 2 | Healthcare | 14.16% |
| 3 | Financials | 12.95% |
| 4 | Consumer Discretionary | 9.77% |
| 5 | Industrials | 9.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
FBMS
2151
DELISTED
The First Bancshares, Inc.
FBMS
| $3.06M | ﹤0.01% |
95,465
+6,109
| +7% | +$196K |
|
2152
Opko Health
OPK
$1.12B
| $3.05M | ﹤0.01% |
2,441,064
+239,428
| +11% | +$299K |
|
|
SAFE
2153
Safehold
SAFE
$1.15B
| $3.05M | ﹤0.01% |
63,840
-10,695
| -14% | -$510K |
|
|
PNT
2154
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $3.01M | ﹤0.01% |
413,536
+150,424
| +57% | +$1.1M |
|
2155
Joby Aviation
JOBY
$11.7B
| $3.01M | ﹤0.01% |
695,875
-34,076
| -5% | -$147K |
|
2156
Ligand Pharmaceuticals
LGND
$3.24B
| $3.01M | ﹤0.01% |
44,994
-38,198
| -46% | -$2.55M |
|
2157
Adeia
ADEA
$1.65B
| $3.01M | ﹤0.01% |
316,999
-1,056,063
| -77% | -$10M |
|
2158
Fate Therapeutics
FATE
$118M
| $3M | ﹤0.01% |
297,483
+37,533
| +14% | +$379K |
|
2159
BlueLinx
BXC
$628M
| $2.99M | ﹤0.01% |
42,061
-4,277
| -9% | -$304K |
|
2160
Oscar Health
OSCR
$5.02B
| $2.99M | ﹤0.01% |
1,213,587
+580,220
| +92% | +$1.43M |
|
2161
Astec Industries
ASTE
$1.06B
| $2.98M | ﹤0.01% |
73,313
-10,021
| -12% | -$407K |
|
2162
Ichor Holdings
ICHR
$567M
| $2.98M | ﹤0.01% |
111,018
-19,508
| -15% | -$523K |
|
2163
Schrodinger
SDGR
$1.34B
| $2.96M | ﹤0.01% |
158,255
+1,008
| +0.6% | +$18.8K |
|
2164
Seaboard Corp
SEB
$3.72B
| $2.95M | ﹤0.01% |
782
+75
| +11% | +$283K |
|
2165
Douglas Dynamics
PLOW
$751M
| $2.95M | ﹤0.01% |
81,631
-23,279
| -22% | -$842K |
|
|
NVTA
2166
DELISTED
Invitae Corporation
NVTA
| $2.95M | ﹤0.01% |
1,586,113
+690,816
| +77% | +$1.28M |
|
2167
Arcus Biosciences
RCUS
$1.25B
| $2.94M | ﹤0.01% |
142,316
-24,359
| -15% | -$504K |
|
2168
Community Trust Bancorp
CTBI
$1.04B
| $2.93M | ﹤0.01% |
63,869
-7,280
| -10% | -$334K |
|
2169
Pitney Bowes
PBI
$1.96B
| $2.93M | ﹤0.01% |
771,838
-179,337
| -19% | -$681K |
|
2170
Resources Connection
RGP
$167M
| $2.93M | ﹤0.01% |
159,427
+35,285
| +28% | +$649K |
|
2171
Inogen
INGN
$225M
| $2.93M | ﹤0.01% |
148,493
+55,466
| +60% | +$1.09M |
|
2172
Hillman Solutions
HLMN
$1.93B
| $2.92M | ﹤0.01% |
404,961
-66,683
| -14% | -$481K |
|
|
PYCR
2173
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
| $2.91M | ﹤0.01% |
118,990
+5,963
| +5% | +$146K |
|
2174
US Physical Therapy
USPH
$1.23B
| $2.91M | ﹤0.01% |
35,895
-2,274
| -6% | -$184K |
|
2175
Healthcare Services Group
HCSG
$1.15B
| $2.91M | ﹤0.01% |
242,178
-132,657
| -35% | -$1.59M |
|